Comparison of intraocular pressure changes in Japanese patients with neovascular age-related macular degeneration treated with aflibercept or faricimab
Japanese Journal of Ophthalmology · 2025
DOI: 10.1007/s10384-024-01155-2 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Japanese Journal of Ophthalmology, 2025. Verfasst von Junichiro Honjo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Fukushima Medical University, Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan. Hauptthemen laut MEDLINE: Recombinant Fusion Proteins, Receptors, Vascular Endothelial Growth Factor, Intraocular Pressure, Wet Macular Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To assess the short-term changes in intraocular pressure (IOP) following intravitreal injections of aflibercept or faricimab in Japanese patients with neovascular age-related macular degeneration (nAMD). STUDY DESIGN: Retrospective observational study. METHODS: This retrospective observational study included 161 eyes from 160 Japanese patients diagnosed with nAMD. Of these, 127 eyes (127 patients) were treated with 2 mg/0.05 mL aflibercept, and 34 eyes (33 patients) received 6 mg/0.05 mL faricimab. Each group underwent three consecutive monthly injections. The IOP in each treated eye was measured using non-contact tonometry at each visit over a 3-month period following the initial injection. RESULTS: The mean baseline IOP in the aflibercept group was 14.4 ± 2.8 mmHg, decreasing to 13.2 ± 3.0 mmHg after 3 months (P < 0.001), whereas the mean baseline IOP in the faricimab group was 13.8 ± 2.1 mmHg, with a change to 13.5 ± 1.5 mmHg after 3 months (P = 0.1873). CONCLUSION: The loading phase treatment with aflibercept resulted in a decrease in IOP. Faricimab showed a similar trend, there was no significant difference between the two treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Fukushima Medical University, Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.
- Department of Ophthalmology, Fukushima Medical University, Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan. sekiryu@fmu.ac.jp.
Zitieren
APA
Honjo, J., Mukai, R., Itagaki, K., Tanaka, K., Norikawa, K., Kato, Y., Kasai, A., Sugano, Y., & Sekiryu, T. (2025). Comparison of intraocular pressure changes in Japanese patients with neovascular age-related macular degeneration treated with aflibercept or faricimab. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-024-01155-2
Vancouver
Honjo J, Mukai R, Itagaki K, Tanaka K, Norikawa K, Kato Y, et al. Comparison of intraocular pressure changes in Japanese patients with neovascular age-related macular degeneration treated with aflibercept or faricimab. Japanese Journal of Ophthalmology. 2025. doi:10.1007/s10384-024-01155-2
BibTeX
@article{Honjo2025,
author = {Honjo, Junichiro and Mukai, Ryo and Itagaki, Kanako and Tanaka, Keiichiro and Norikawa, Koki and Kato, Yutaka and Kasai, Akihito and Sugano, Yukinori and Sekiryu, Tetsuju},
title = {Comparison of intraocular pressure changes in Japanese patients with neovascular age-related macular degeneration treated with aflibercept or faricimab},
journal = {Japanese Journal of Ophthalmology},
year = {2025},
doi = {10.1007/s10384-024-01155-2}
}
EUVIMED